IL159526A0 - Use of corticotroph-derived glycoprotein hormone to induce lipolysis - Google Patents

Use of corticotroph-derived glycoprotein hormone to induce lipolysis

Info

Publication number
IL159526A0
IL159526A0 IL15952602A IL15952602A IL159526A0 IL 159526 A0 IL159526 A0 IL 159526A0 IL 15952602 A IL15952602 A IL 15952602A IL 15952602 A IL15952602 A IL 15952602A IL 159526 A0 IL159526 A0 IL 159526A0
Authority
IL
Israel
Prior art keywords
corticotroph
glycoprotein hormone
derived glycoprotein
induce lipolysis
lipolysis
Prior art date
Application number
IL15952602A
Other languages
English (en)
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of IL159526A0 publication Critical patent/IL159526A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15952602A 2001-07-13 2002-07-15 Use of corticotroph-derived glycoprotein hormone to induce lipolysis IL159526A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30528401P 2001-07-13 2001-07-13
PCT/US2002/022747 WO2003006051A1 (en) 2001-07-13 2002-07-15 Use of corticotroph-derived glycoprotein hormone to induce lipolysis

Publications (1)

Publication Number Publication Date
IL159526A0 true IL159526A0 (en) 2004-06-01

Family

ID=23180168

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15952602A IL159526A0 (en) 2001-07-13 2002-07-15 Use of corticotroph-derived glycoprotein hormone to induce lipolysis

Country Status (7)

Country Link
US (2) US20030095983A1 (enExample)
EP (1) EP1414485A1 (enExample)
JP (1) JP2004521952A (enExample)
CA (1) CA2454181A1 (enExample)
IL (1) IL159526A0 (enExample)
WO (1) WO2003006051A1 (enExample)
ZA (1) ZA200400060B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2396283A1 (en) * 2000-01-18 2001-07-26 Akzo Nobel N.V. Human cystine knot polypeptide
AU2003273862A1 (en) * 2002-06-10 2003-12-22 Zymogenetics, Inc. Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
CA2547631A1 (en) * 2003-12-05 2005-06-23 Zymogenetics, Inc. Methods for treating inflammation using thyroid stimulating hormone
US20050272635A1 (en) * 2004-03-05 2005-12-08 Kelly James D Use of corticotroph-derivced glycoprotein hormone to treat liver steatosis
JP5118292B2 (ja) * 2005-06-16 2013-01-16 株式会社ロッテ 脂肪分解促進剤
US20070014736A1 (en) * 2005-06-29 2007-01-18 Okada Shannon L Methods of delivering corticotroph-derived glycoprotein hormone
DK1971361T3 (da) 2005-12-23 2014-09-08 James D Kelly Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002503467A (ja) * 1998-02-13 2002-02-05 ザイモジェネティクス，インコーポレイティド 新規シスチン結節タンパク質及びそれを製造するための材料及び方法
AU5491900A (en) * 1999-06-17 2001-01-09 Amgen, Inc. Glycoprotein hormone family member
US20020068279A1 (en) * 1999-12-06 2002-06-06 Curagen Corporation Novel Proteins and nucleic acids encoding the same
US7514239B2 (en) * 2000-03-28 2009-04-07 Amgen Inc. Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
US20040005554A1 (en) * 2000-05-08 2004-01-08 Tayar Nabil El Novel glycoproteins and methods of use thereof

Also Published As

Publication number Publication date
US20060035818A1 (en) 2006-02-16
JP2004521952A (ja) 2004-07-22
WO2003006051A1 (en) 2003-01-23
EP1414485A1 (en) 2004-05-06
US20030095983A1 (en) 2003-05-22
CA2454181A1 (en) 2003-01-23
ZA200400060B (en) 2004-08-17

Similar Documents

Publication Publication Date Title
GB0103973D0 (en) Improvements relating to skin prickers
IL208892A0 (en) Use of hmg fragment as anti-inflammatory agents
EP1404343A4 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES
AU2002364893A8 (en) Delivery of medicaments to the nail
GB0103977D0 (en) Improvements relating to skin prickers
IL159632A0 (en) Process and intermediates to prepare latanoprost
IL160928A0 (en) Use of histamine to treat liver disease
HRP20030874A2 (en) Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
EP1373221A4 (en) NOVEL CYANO SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THERATEUTIC USE THEREOF
EP1399175A4 (en) THERAPEUTIC USE OF RANK ANTAGONISTS
IL159526A0 (en) Use of corticotroph-derived glycoprotein hormone to induce lipolysis
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
HUP0401589A3 (en) New peptides - analogs of human growth hormone-releasing hormone
AU2003220201A8 (en) Purification and cloning of nmn adenylyltranserase and its therapeutic use
GB0222338D0 (en) Surface treatment of concrete
TW423322U (en) Improved structure of massage pad
EP1451308A4 (en) THERAPEUTIC USE OF AZIRIDINO COMPOUNDS
TW552926U (en) Improved structure of thermal dressing bag
PL347347A1 (en) Apparatus enabling paraparesic persons to walk
TW507567U (en) Improved structure of gloves for shower use
TW497384U (en) Improved structure of baby blanket
TW423321U (en) Improved structure of multifunctional massage pad
TW406718U (en) Hand grip structure improvement of screed
TW459847U (en) Structure of anti-quake fastening piece for stone
GB0129049D0 (en) Improvements to self-sterilisation of surfaces